Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00659672 · ClinicalTrials.gov registry record · NA

Effect of Whey Protein on Blood Pressure

A NA study of High Blood Pressure, sponsored by United States Department of Agriculture (USDA).

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT00659672: Completed NA study of High Blood Pressure, sponsored by United States Department of Agriculture (USDA).

NCT00659672 is a NA study of High Blood Pressure that has completed, run by United States Department of Agriculture (USDA). The registered enrollment target is 35 participants, below the 503-participant average among 23 other High Blood Pressure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00659672, a NA study of High Blood Pressure, has completed, sponsored by United States Department of Agriculture (USDA).

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if consumption of whey protein, compared with soy protein or a carbohydrate food decreases blood pressure along with reducing risk factors for heart disease.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey Protein
  • DIETARY_SUPPLEMENT Soy Protein
  • DIETARY_SUPPLEMENT Control (carbohydrate)

Study Locations (1)

Maryland

  • USDA Beltsville Human Nutrition Research Center - Beltsville

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2008-09
Est. Completion 2009-02
Phase NA

What the finished NCT00659672 record still lists

NCT00659672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 503-participant average among 23 other High Blood Pressure trials with a reported enrollment target (93% lower).

The record links to 1 condition, with High Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Whey Protein is the first listed.

NCT00659672 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00659672 about?

NCT00659672 is a clinical study titled "Effect of Whey Protein on Blood Pressure". The purpose of this study is to determine if consumption of whey protein, compared with soy protein or a carbohydrate food decreases blood pressure along with reducing risk factors for heart disease.

What is the current status of trial NCT00659672?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2008-09. Estimated completion is 2009-02.

What conditions does trial NCT00659672 study?

This clinical trial studies the following conditions: High Blood Pressure.

What interventions are being tested in trial NCT00659672?

The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT), Soy Protein (DIETARY_SUPPLEMENT), Control (carbohydrate) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00659672?

This trial is sponsored by United States Department of Agriculture (USDA), which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00659672 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for High Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00659672's enrollment target sits among peer trials

35 18th of 23 higher than 6 of 23 other High Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other High Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00659672, the US trial registry maintained by the National Library of Medicine. NCT00659672 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.